+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06913296

Evaluating PTeye Autofluorescence Device and Biochemical Markers in Adults Undergoing Parathyroidectomy for Parathyroid Adenoma

Led by Aristotle University Of Thessaloniki · Updated on 2025-04-06

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying parathyroid adenoma patients to evaluate how the PTeye near-infrared autofluorescence device correlates with biochemical data during parathyroidectomy surgery. Identifying the parathyroid glands is essential for successful surgery, and this study aims to assess the usefulness of PTeye, a probe-based autofluorescence system, compared to biochemical markers. Patients undergoing typical open parathyroidectomy will have their parathyroid glands identified using the PTeye device. During surgery, the autofluorescence values recorded by the PTeye after gland recognition will be collected and analyzed. The study focuses on comparing these values with biochemical data collected intraoperatively and on the first day after surgery. Participants will be involved during their surgery when PTeye readings are taken, and biochemical tests will be done during and shortly after surgery. The main measurement is the correlation between PTeye values and biochemical markers related to parathyroid adenoma. This observational study does not involve additional treatment beyond standard surgery and monitors outcomes through routine biochemical assessments.

CONDITIONS

Brief Title

PTeye in Parathyroid Adenoma

Research Team

T

Theodossis Papavramidis, Professor of Surgery

A

Angeliki Chorti, Dr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here